Related Experiment Video
Updated: Aug 13, 2026
05:42
An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
Published on: January 26, 2024
Ovarian Cancer Mortality Trend in Montenegro, 1990-2018
Mirjana Nedovic Vukovic1, Marina Jakšic2, Dragan Lauševic3
1Associate, Director of the Center for Health System Evidence and Research in Public Health, Institute for Public Health of Montenegro, Podgorica, Montenegro.
Indian Journal of Public Health
|August 10, 2026
Summary
Ovarian cancer mortality in Montenegro shows an increasing trend from 1990-2018, with rates rising 1.9% annually. Further research is needed to understand the causes of this concerning trend in women's cancer deaths.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Ovarian cancer is a leading cause of cancer death in women.
- Lack of early screening programs contributes to low survival rates.
- This study focuses on ovarian cancer mortality trends in Montenegro.
Purpose of the Study:
- To investigate trends in ovarian cancer mortality in Montenegro between 1990 and 2018.
- To analyze age-standardized mortality rates and identify specific age groups affected.
- To utilize regression techniques for trend analysis.
Main Methods:
- Collected ovarian cancer mortality data for Montenegro (1990-2018).
- Age-standardized mortality rates to the World Standard Population.
- Employed joinpoint, linear, and Poisson regression analyses.
Main Results:
- 418 deaths from ovarian cancer were recorded between 1990-2018.
- Average annual age-standardized mortality rate was 3.0/100,000.
- Ovarian cancer mortality rates increased by an average of 1.9% annually (AAPC).
- The number of cases increased by 3.5% per year.
- Highest mortality rates observed in women aged 65-84 years.
Conclusions:
- Ovarian cancer mortality shows an unfavorable increasing trend in Montenegro.
- The underlying reasons for this rise remain unclear.
- Highlights the need for increased attention and further research into ovarian cancer.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:08Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...